Selecta Biosciences' Series E - III Round

Selecta Biosciences raised a round of funding on October 15, 2014.

Selecta Biosciences is a biopharmaceutical company developing a new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic a…

Articles about Selecta Biosciences' Series E - III Round: